http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004000313-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b840f4b6a85562e9b3029ae67fce1d95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a76974adc0fca5b4718fa207d636dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bb6db818f0c67efdde3038c80baaacf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-425
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
filingDate 2003-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eea2debb078ddebfd9ff47d008783112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e722be2a31fd9094311fb1c9ee75d54
publicationDate 2003-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004000313-A2
titleOfInvention Treatment of amyotrophic lateral sclerosis using pgc-1 activity-modulating compounds
abstract The invention relates to the field of biology, genetics and medicine. More specifically, the invention relates to novel methods of treating (or managing) amyotrophic lateral sclerosis. The invention also relates to methods of identifying or screening active compounds in said pathology. The invention further relates to compounds, genes, cells, plasmids or compositions that are used to carry out the above-mentioned methods. In particular, the invention describes the role of PGC1 in said pathology and the use thereof as a therapeutic target.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016531162-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709704-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1802321-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015042286-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1802321-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011074690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7947652-B2
priorityDate 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0135096-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0058473-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127526308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127895450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12040205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11865464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128898221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127856099
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129200050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17756782
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129317935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070

Total number of triples: 54.